GC
CNMD icon

Globeflex Capital’s CONMED CNMD Stock Holding History

Globeflex Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,496
Closed -$1.39M – 531
2019
Q3 		$1.39M Sell
14,496
-1,304
-8% -$122K 0.3% 89
2019
Q2 		$1.35M Sell
15,800
-19
-0.1% -$1.56K 0.28% 95
2019
Q1 		$1.32M Hold
15,819
– – 0.28% 110
2018
Q4 		$1.02M Buy
15,819
+4,301
+37% +$294K 0.24% 137
2018
Q3 		$912K Buy
11,518
+3,300
+40% +$255K 0.18% 197
2018
Q2 		$602K Buy
+8,218
New +$559K 0.12% 266
2013
Q4 		– Sell
-11,142
Closed -$378K – 629
2013
Q3 		$378K Sell
11,142
-38
-0.3% -$1.24K 0.05% 300
2013
Q2 		$349K Buy
+11,180
New +$363K 0.05% 314

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Globeflex Capital's CNMD Position: Q4 2019 in Review

Globeflex Capital sold out of CONMED (CNMD) in Q4 2019, closing a stake of 14,496 shares — an estimated $1.39M sold.

Globeflex Capital first reported a position in CNMD in Q2 2013 and held it in 8 quarters. The position peaked at $1.39M in Q3 2019. 264 funds tracked by Wall St. Rank hold CNMD as of Q4 2019.

  • Globeflex Capital reported no remaining CONMED position as of Q4 2019 after selling out during the quarter.
  • Globeflex Capital sold 14,496 CONMED shares in Q4 2019, an estimated $1.39M.
  • Globeflex Capital first reported a position in CONMED in Q2 2013 and held it in 8 quarters.
  • Globeflex Capital's CONMED position peaked at $1.39M in Q3 2019.
  • 264 funds tracked by Wall St. Rank held CONMED as of Q4 2019.

Based on Globeflex Capital's 13F filing for Q4 2019, filed 7 Feb 2020.